MediciNova announced positive signals from its Phase 2 trial of MN-001 (tipelukast) for nonalcoholic fatty liver disease and hypertriglyceridemia in type 2 diabetes, showing significant improvements in HDL cholesterol and early triglyceride reduction, though primary endpoints were not met. The drug was well tolerated with no serious adverse events. The company is analyzing full data to decide next steps. Additionally, MediciNova is nearing completion of its Phase 2b/3 trial for MN-166 (ibudilast) in ALS, with topline results expected by year-end, aiming to advance treatment options for this serious disease.
MediciNova CEO's shareholder update provides context for health sector investors. As of Oct 12, 2026 15:02 WIB, 60 of 128 priced Health-sector US stocks on Pluang rose while 29 fell. Notable movers include NUWE at USD 0.70 with a 1-day change of +1.60%, Moderna at USD 228.58 up +1.59%, and ADMA Biologics at USD 10.20 down -1.54%.
Flyte Aviation announced record preliminary third quarter 2026 revenue of approximately $2.15 million, a 110% increase from the previous quarter. The growth was driven by a 150% rise in the aviation segment and a surge in users on its redesigned digi...
Since September 2025, Bloom Energy's stock price has experienced five separate declines of 20% or more. Despite these sharp drops, the stock has shown resilience by recovering from four of these declines within a few weeks. This pattern highlights th...
The global hot water boilers market is projected to grow from $31.5 billion in 2026 to $51.31 billion by 2036, at a 5% CAGR. Growth is fueled by demand for energy-efficient heating, modernization of infrastructure, and integration of smart controls. ...
The global textile recycling market is projected to grow from $6.4 billion in 2026 to $14.2 billion by 2036, at a CAGR of 7.5%. Growth is fueled by regulatory pressures like EPR mandates, corporate recycled-content targets, and investments in circula...
The global semiconductor ultrapure water systems market is projected to grow from USD 2.2 billion in 2026 to USD 4.7 billion by 2036, at an 8.0% CAGR. Growth is fueled by expanding semiconductor fabrication capacity, stricter water purity needs for a...
